SCHEMBL7124088

SCHEMBL7124088

CCOP(=O)(OCC)C(c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)N(C)Cc1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.47
RIPK1 Q13546 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
LMNA P02545 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
MC4R P32245 1/20 0.39
HTT P42858 1/20 0.39
CCR6 P51684 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALOX5 P09917 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
CHRNB2 P17787 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766635 0.87 NR1H4 (0.43) RIPK1NR1H4LMNAALDH1A1MAPT
SCHEMBL7123113 0.85 PKM (0.41) ALDH1A1MAPTTP53ALOX15NPSR1
SCHEMBL8003353 0.79 HMGCR (0.47) HMGCRNR1H4LMNAALDH1A1MAPT
SCHEMBL7128247 0.77 HMGCR (0.47) HMGCRLMNAALDH1A1MAPTHTT
SCHEMBL7122163 0.76 NR1H4 (0.42) HMGCRRIPK1NR1H4ALDH1A1ALOX5
SCHEMBL7119145 0.75 HMGCR (0.46) HMGCRLMNAALDH1A1MAPTTP53
SCHEMBL8150112 0.75 ALDH1A1 (0.43) HMGCRRIPK1NR1H4LMNAALDH1A1
SCHEMBL8766148 0.72 HMGCR (0.46) HMGCRLMNAALDH1A1MAPTKMT2A
SCHEMBL7127837 0.70 GAA (0.38) LMNAALDH1A1MAPTTP53ALOX15
SCHEMBL8766586 0.70 MEN1 (0.43) HMGCRLMNAALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835116-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYMPHAR S.A. (CH) 1998-04-15 EP claimed
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP claimed
WO-1997002037-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYMPHAR S.A. (CH) 1997-01-23 WO claimed
US-5424303-A For treating hypercholesterolemia and hyperlipidemia SYMPHAR SA (CH) 1995-06-13 US claimed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP claimed
US-6660724-B1 Aminophosphonates alpha substituted by phenol; lipoprotein lowering activity ILEX PRODUCTS, INC. 2003-12-09 US disclosed
US-6060464-A Compounds and pharmaceutical compositions containing them SMITHKLINE BEECHAM P.L.C. (GB) 2000-05-09 US disclosed
EP-0835116-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYMPHAR S.A. (CH) 1998-04-15 EP disclosed
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP disclosed
WO-1997002037-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYMPHAR S.A. (CH) 1997-01-23 WO disclosed
US-5424303-A For treating hypercholesterolemia and hyperlipidemia SYMPHAR SA (CH) 1995-06-13 US disclosed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP disclosed